-
1 Comment
SELLAS Life Sciences Group, Inc is currently in a long term uptrend where the price is trading 17.1% above its 200 day moving average.
From a valuation standpoint, the stock is 97.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 36.3.
SELLAS Life Sciences Group, Inc's total revenue rose by inf% to $2M since the same quarter in the previous year.
Its net income has increased by 49.9% to $-4M since the same quarter in the previous year.
Finally, its free cash flow grew by 182.0% to $3M since the same quarter in the previous year.
Based on the above factors, SELLAS Life Sciences Group, Inc gets an overall score of 5/5.
| ISIN | US81642T2096 |
|---|---|
| Sector | Healthcare |
| Exchange | F |
| CurrencyCode | EUR |
| Industry | Biotechnology |
| Market Cap | 146M |
|---|---|
| PE Ratio | None |
| Target Price | 18.5 |
| Beta | 2.54 |
| Dividend Yield | None |
SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for RXK3.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
